PROCEPT BioRobotics (PRCT): The Aquablation Prostate Robot at a 52-Week Low | Jul 16, 2026
PROCEPT BioRobotics (NASDAQ: PRCT) is a Layer 7 surgical-robotics pure-play whose AQUABEAM and HYDROS robots deliver "Aquablation therapy" — a heat-free, robotically guided waterjet that removes excess prostate tissue to treat an enlarged prostate (BPH), a condition PROCEPT says affects roughly 40 million U.S. men. In this casual-investor deep dive, Elena and Theo explain where PROCEPT sits in the robotics value chain and why it's a genuine robotics business rather than a sticker on a box: the razor-and-blades model of a ~$485,000 robot plus a ~$3,500 single-use handpiece per procedure, a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.